Product Information
SYMLINPEN 60 PEN INJECTOR is a brand product labeled by AstraZeneca Pharmaceuticals LP, priced at $330.9522 per ML under NDC 00310661502. Its NADAC has been published 348 times since May 20, 2015.
Strength
1000 ug/mL
Manufacturer
AstraZeneca Pharmaceuticals LPNDC
00310661502
Classification
Brand
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Last Updated
6/18/2025
Active Ingredients
PRAMLINTIDE ACETATEApproval Type
New Drug (NDA)
FDA Application
NDA021332On Market Since
1/8/2015
Pharmacological Classes
Price Statistics
The NADAC for SYMLINPEN 60 PEN INJECTOR has been published 348 times since May 20, 2015, and over the history we have for it it has risen 74.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $330.9522 per ML |
|---|---|
| All-time high | $331.5452 (Jun 11, 2025) |
| All-time low | $189.2783 (May 20, 2015) |
| 52-week high | $330.9522 |
| 52-week low | $330.9522 |
| Median price | $284.9175 |
| Average price | $279.1658 |
| Largest weekly change | +15.0% (Jun 22, 2016) |
| Weeks tracked | 348 |
| Tracking since | May 20, 2015 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 34% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SYMLINPEN 60 PEN INJECTOR?
The current National Average Drug Acquisition Cost (NADAC) for SYMLINPEN 60 PEN INJECTOR, manufactured by AstraZeneca Pharmaceuticals LP, is $330.9522 per ML (NDC 00310661502), effective Jun 10, 2026.
How has the price of SYMLINPEN 60 PEN INJECTOR changed over time?
Over the history we have for it, the NADAC for SYMLINPEN 60 PEN INJECTOR has risen 74.8%. It has been tracked across 348 weekly CMS publications since May 20, 2015.
What are the highest and lowest recorded NADAC prices for SYMLINPEN 60 PEN INJECTOR?
Since May 20, 2015, the NADAC for SYMLINPEN 60 PEN INJECTOR has ranged from a low of $189.2783 (May 20, 2015) to a high of $331.5452 (Jun 11, 2025), with a median of $284.9175 per ML.
Are there cheaper alternatives to SYMLINPEN 60 PEN INJECTOR?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, SYMLINPEN 120 PEN INJECTOR, is $217.5214 per ML — about 34% below SYMLINPEN 60 PEN INJECTOR.
Who manufactures SYMLINPEN 60 PEN INJECTOR?
SYMLINPEN 60 PEN INJECTOR (NDC 00310661502) is labeled by AstraZeneca Pharmaceuticals LP, and CMS classifies it as a brand product.
Related Drugs
Same classification